Access to health and social services for IDU: The impact of a medically supervised injection facility

Drug and Alcohol Review

Volumn 28, Issue 4, 2009, Pages 341-346

  Small, Will ^a   Van Borek, Natasha ^a   Fairbairn, Nadia ^a   Wood, Evan ^a,b   Kerr, Thomas ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Health and social service; Injection drug use; Supervised injection

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANADA; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE DELIVERY; HEALTH PROMOTION; HUMAN; INFORMATION PROCESSING; MALE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PATIENT REFERRAL; PREVENTIVE HEALTH SERVICE; PSYCHOLOGICAL ASPECT; STATISTICS; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; BRITISH COLUMBIA; DATA COLLECTION; FEMALE; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; PATIENT ACCEPTANCE OF HEALTH CARE; REFERRAL AND CONSULTATION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 70349330625     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2009.00025.x     Document Type: Article

References (28)

1. Grund JP, Blanken P, Adriaans NF, Kaplan CD, Barendregt C, Meeuwsen M. Reaching the unreached: Targeting hidden IDU populations with clean needles via known user groups. J Psychoactive Drugs 1992;24:41-7.
2. Drumm RD, McBride DC, Metsch L, Page JB, Dickerson K, Jones B. The rock always comes first: Drug users' accounts about using formal health care. J Psychoactive Drugs 2003;35:461-9.
3. Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the 'narc' cabinet. J Gen Intern Med 2002;17:327-33.
4. Neale J, Sheard L, Tompkins CN. Factors that help injecting drug users to access and benefit from services: a qualitative study. Subst Abuse Treat Prev Policy 2007; 2:31.
5. Drumm RD, McBride DC, Metsch L, Neufeld M, Sawatsky A. 'I'm a health nut!': street drug users' accounts of self-care strategies. J Drug Iss 2005;35:607-29.
6. McCoy CB, Metsch L, Chitwood DD, Miles C. Drug use and barriers to use of health care services. Subst Use Misuse 2001;36:789-806.
7. Kerr T, Wood E, Grafstein E, et al. High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health (Oxf) 2004;27:62-6.
8. Topp L, Iversen J, Conroy A, Salmon AM, Maher L. Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs. Aust N Z J Public Health 2008;32:34-7.
9. Neale J, Tompkins C, Sheard L. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. Health Soc Care Community 2008;16:147-54.
10. Neale J, Godfrey C, Parrott S, Sheard L, Tompkins C. Barriers to the effective treatment of injecting drug users. London: Department of Health, 2007.
11. Heinzerling KG, Kral AH, Flynn NM,et al. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend 2006;81:167-78.
12. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997;11:F59-65.
13. Wood E, Kerr T, Tyndall MW, Montaner JS. A review of barriers and facilitators of HIV treatment among injection drug users. AIDS 2008;22:1247-56.
14. Broadhead RS, Kerr TH, Grund J-PC, Altice FL. Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues 2002;32:329-55.
15. Rhodes T, Ball A, Stimson GV, et al. HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. Addiction 1999;94:1323-36.
16. Tyndall MW, Kerr T, Zhang R, King E, Montaner J, Wood E. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug Alcohol Depend 2006;83:193-8.
17. Wood E, Tyndall M, Zhengou Q, Zhang R, Montaner J, Kerr T. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. Am J Public Health 2006;96: 770-3.
18. Wood E, Tyndall M, Montaner J, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ 2006;175:1399-404.
19. Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting drug users. Addiction 2007; 102:916-19.
20. Wood E, Kerr T, Lloyd-Smith E, et al. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J 2004;1:9.
21. Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy 2007;18:306-12.
22. Laine C, Lin YT, Hauck W, Turner BJ. Availability of medical care services in drug treatment clinics associated with lower repeated emergency department use. Med Care 2005;43:985-95.
23. Friedmann P, Hendrickson JC, Gerstein DR, Zhang Z, Stein MD. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care 2006;44:8-15.
24. Laine C, Hauck W, Gourevitch MN, Rothman J, Cohen A, Turner BJ. Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA 2001;285:2355-62.
25. Strathdee SA, Celentano DD, Shah N, et al. Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health 1999;76:448-60.
26. Riley ED, Wu AW, Junge B, Marx M, Strathdee SA, Vlahov D. Health services utilization by injection drug users participating in a needle exchange program. Am J Drug Alcohol Abuse 2002;28:497-511.
27. Wood E, Kerr T, Montaner JS. Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect Dis 2004;4:301-6.
28. Kimber J, Mattick RP, Kaldor J, van Beek I, Gilmour S, Rance JA. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Drug Alcohol Rev, in press.